Real‐world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany-Reference-Cited by-同舟云学术

Real‐world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany

Published:2019-04-11 Issue:5 Volume:21 Page:588-597
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Wachter Rolf¹²,Fonseca Ana F.³,Balas Bogdan⁴⁵,Kap Elisabeth⁶,Engelhard Johanna⁶,Schlienger Raymond⁴,Klebs Sven⁷,Wirta Sara Bruce⁸,Kostev Karel⁶

Affiliation:

1. Clinic and Polyclinic for CardiologyUniversity Hospital Leipzig Leipzig Germany

2. German Cardiovascular Research CenterPartner Site Göttingen Göttingen Germany

3. Wellmera AG Basel Switzerland

4. Novartis Pharma AG Basel Switzerland

5. F. Hoffmann‐La Roche Ltd Basel Switzerland

6. IQVIA Germany (IQVIA Commercial GmbH & Co. OHG) Frankfurt Germany

7. Novartis Pharma GmbH Nuremberg Germany

8. Novartis Sweden AB Stockholm Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1465

Reference30 articles.

1. European Medicines Agency. Summary of Product Characteristics Entresto.2015.https://www.ema.europa.eu/documents/product‐information/entresto‐epar‐product‐information_en.pdf(11 March 2019).

2. European Medicines Agency. EPAR Summary for the public Entresto. 2015.http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Summary_for_the_public/human/004062/WC500197539.pdf(11 March 2019).

3. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

4. Pharmazeutische Zeitung. Sacubitril/valsartan|Entresto®|53|2016.https://www.pharmazeutische‐zeitung.de/arzneistoffe/daten/2016/sacubitrilvalsartanentrestor532016(11 March 2019).

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of diuretic deprescribing in adult patients: A systematic review to inform an evidence‐based diuretic deprescribing guideline;British Journal of Clinical Pharmacology;2024-08-08

2. Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry;J CARDIOL;2024

3. Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan;Journal of Clinical Medicine;2024-05-30

4. Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany;European Journal of Clinical Pharmacology;2024-03-12

5. German longitudinal prescription database (LRx): Description of characteristics, use in pharmacoepidemiological research, and limitations;Int. Journal of Clinical Pharmacology and Therapeutics;2024-01-01